Maximus Inc. (MMS) Business Metric Overview - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Maximus Inc.

    NYSE: MMS · Real-Time Price · USD
    89.28
    1.16 (1.32%)
    At close: Sep 29, 2025, 3:59 PM
    91.07
    2.01%
    After-hours: Sep 29, 2025, 06:51 PM EDT

    Maximus Revenue Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024
    Clinical Services Revenue 560.36M 503.96M 471.53M
    Clinical Services Revenue Growth +11.19% +6.88% n/a
    Technology Solutions Revenue 79.15M 88.06M 89.56M
    Technology Solutions Revenue Growth -10.12% -1.68% n/a

    Revenue by Geography

    Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018
    Australia Revenue 30M 43.59M 46.67M 52.81M 52.83M 65.28M 70.95M 55.93M 46.77M 38.41M 24.54M 37.44M 45.68M 48.74M 51M 53.37M
    Australia Revenue Growth -31.18% -6.59% -11.63% -0.04% -19.07% -7.98% +26.85% +19.60% +21.74% +56.54% -34.45% -18.05% -6.28% -4.42% -4.45% n/a
    Rest Of World Revenue 37.06M 47.58M 51.39M 43.97M 45.72M 50.19M 37.1M 34.66M 26.25M 22.47M 27.78M 28.94M 27.02M 26.27M 26.72M 26.63M
    Rest Of World Revenue Growth -22.10% -7.43% +16.89% -3.83% -8.91% +35.27% +7.05% +32.05% +16.83% -19.14% -3.99% +7.09% +2.85% -1.66% +0.33% n/a
    United Kingdom Revenue 107.11M 109.78M 107.9M 85.81M 74.66M 74.11M 72.88M 64.79M 56.25M 53.36M 63.72M 73M 69.68M 72.27M 78.33M 73.42M
    United Kingdom Revenue Growth -2.43% +1.74% +25.74% +14.94% +0.74% +1.68% +12.50% +15.18% +5.40% -16.25% -12.71% +4.77% -3.58% -7.75% +6.70% n/a
    United States Revenue 1B 924.84M 971.37M 968.29M 932.92M 1.05B 778.35M 790.18M 794.58M 787.09M 702.09M 678.85M 612.58M 583.43M 580.47M 511.2M
    United States Revenue Growth +8.44% -4.79% +0.32% +3.79% -11.48% +35.41% -1.50% -0.55% +0.95% +12.11% +3.42% +10.82% +5.00% +0.51% +13.55% n/a

    Operating Expense Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
    Selling, General, and Administrative Revenue 170.83M 162.86M 191.74M 166.9M 166.68M 168.23M 169.19M 167.78M 182.54M 142.45M 146.45M 146.99M 132.97M 130.31M 124.22M 129.59M 140.13M 112.4M 111.97M 103.43M 89.58M 106.85M 87.23M 81.65M 81.6M 78.1M 79.67M 73.53M 69.59M 72.56M 69.56M 82.21M 68.31M 68.6M 65.4M 68.34M 69.71M 65.98M 64.23M 60.44M 67M 59.39M
    Selling, General, and Administrative Revenue Growth +4.90% -15.06% +14.88% +0.13% -0.92% -0.57% +0.84% -8.09% +28.15% -2.73% -0.37% +10.54% +2.05% +4.90% -4.14% -7.52% +24.67% +0.39% +8.26% +15.46% -16.16% +22.50% +6.84% +0.05% +4.48% -1.97% +8.34% +5.67% -4.09% +4.31% -15.39% +20.35% -0.42% +4.89% -4.31% -1.96% +5.65% +2.71% +6.27% -9.78% +12.80% n/a
    Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist